RA273: R=rubella,
A=abortus, 27=27th fetus tested, 3=3rd tissue explanted
Used in the Rubella/MMR vaccine
The Wistar Institute located in Philadelphia, PA collected aborted fetal tissue
from 27 babies aborted during the rubella epidemic of 1964 in an attempt to
isolate the virus specifically for vaccine development.
The 27 women exposed to or infected with the virus had abortions at
the advice and encouragement of their doctor, who collaborated with Wistar
to collect and preserve the fetal tissue. It
was from the kidney tissue of the 27th fetus that the virus was
finally found. This virus was then
grown on the WI-38 aborted fetal cell line to produce the rubella vaccine.
WI-38: Wistar Institute fetus number 38
Used in the Rubella/MMR vaccine and the
Chickenpox vaccine as a cell substrate to cultivate the viruses
Derived from the lung tissue of a female baby aborted at 3 months gestation in
the 1960's in Sweden because the parents felt they had too many children.
MRC-5: Medical Research Council fetus number 5
Used in the Acambis 1000 smallpox vaccine, the
Imovax Rabies vaccine, the Chickenpox vaccine and the Hepatitis-A and Twinrix
(Hepatitis A-B combo) vaccines to cultivate the viruses.
Derived from the lung tissue of a male baby aborted at 14 weeks gestation in the
United Kingdom in the 1970's for "psychiatric reasons".
PER C6: Crucell, NV's Designer Cell Substrate
developed specifically for the pharmaceutical industry.
To be used in the Ebola, Flu, HIV and many
future vaccines as a "designer
cell substrate" to cultivate the viruses.
Derived from the retinal tissue of a baby aborted at 18 weeks gestation in the
Netherlands because, according to Dr. Alex Van Der Eb from Crucell at recent FDA
hearings, "The woman wanted to get rid of the fetus. The father was
not known and that is why the abortion was requested."